Innovation Pharmaceuticals Inc (IPIX)

[petemantx]

I take it that P and K are the drugs of IPIX you find possibly non-viable. I believe they are as heavily in play and viable as Brilacidin, but at the current time their progress is simply on hold.

Kevetrin has proven itself in every study it has been in and is already quite far along in developing it into a oral delivery system per IPIX statements in the spring of 2017. It has been on hold due to financial assets being diverted to B and P, but it certainly is as viable as ever. Many seem to forget that the p53 gene, which Kevetrin has shown to activate, is the most researched and published matter in the history of medicine. There is no possible way the medical field will not jump on Kevetrin, when in pill form, with both feet in a big way.

The only hangup with Prurisol is getting the release of the P2b data and that seems to be going to be worked out in the near future with the recent financing. The only problem with the science of Prurisol is in the minds of those posting here regularly that have no foundation whatsoever for their disparaging remarks. Remember, the psoriasis indication is a biggie, but certainly not the biggest of the markets for Prurisol. Like Kevetrin, it has never failed in a trial of any sort in it's history. So to think it doesn't have a great future of becoming a powerhouse drug IMO is way off base and will be proved wrong in the near future.

I understand the hesitation in deeming them powerhouses with no reservations, but all those reservations should be addressed by the end of the year IMO.

Looking forward to another week where expectations for further PRs are running high and they will take everyone by surprise as have the PRs of the past couple of weeks. Exciting times for us longs!!!

Is you moniker based on the John Cleese British comedy show years ago? Too bad it was so short lived as it was wonderful IMO.